GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » Forward PE Ratio

Cognetivity Neurosciences (XCNQ:CGN) Forward PE Ratio : 0.00 (As of Jun. 02, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Forward PE Ratio?

Cognetivity Neurosciences's Forward PE Ratio for today is 0.00.

Cognetivity Neurosciences's PE Ratio without NRI for today is 0.00.

Cognetivity Neurosciences's PE Ratio for today is 0.00.


Cognetivity Neurosciences Forward PE Ratio Historical Data

The historical data trend for Cognetivity Neurosciences's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Forward PE Ratio Chart

Cognetivity Neurosciences Annual Data
Trend 2021-12 2022-12 2023-09
Forward PE Ratio
54.95 20.00 16.00

Cognetivity Neurosciences Quarterly Data
2021-12 2022-03 2022-06 2022-12 2023-03 2023-06
Forward PE Ratio 54.95 39.53 28.99 20.00 28.99 23.98

Competitive Comparison of Cognetivity Neurosciences's Forward PE Ratio

For the Health Information Services subindustry, Cognetivity Neurosciences's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's Forward PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Forward PE Ratio falls into.



Cognetivity Neurosciences Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Cognetivity Neurosciences  (XCNQ:CGN) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Cognetivity Neurosciences Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (XCNQ:CGN) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines